Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke

As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years. We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated. In present study, rats were subjected to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Phytomedicine (Stuttgart) 2018-05, Vol.44, p.20-31
Hauptverfasser: Liu, Bowen, Luo, Cheng, Zheng, Zhaoguang, Xia, Zhenyan, Zhang, Qian, Ke, Chienchih, Liu, Renshyan, Zhao, Yonghua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 31
container_issue
container_start_page 20
container_title Phytomedicine (Stuttgart)
container_volume 44
creator Liu, Bowen
Luo, Cheng
Zheng, Zhaoguang
Xia, Zhenyan
Zhang, Qian
Ke, Chienchih
Liu, Renshyan
Zhao, Yonghua
description As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years. We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated. In present study, rats were subjected to permanent middle cerebral artery occlusion model (MCAo) and were treated with low, middle and high doses of SSS extraction. We assessed neurological function and survival rate, and measured infarct volume by 2,3,5-triphenyltetrazolium chloride staining on day 7 after ischemia. von Willebrand factor (vWF), stromal cell-derived factor-1 alpha (SDF-1α) /chemokine (C-X-C motif) receptor 4 (CXCR4) axis, vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) as well as protein kinase B (AKT)/mammalian target of rapamycin (mTOR) /hypoxia-inducible factor-1 alpha (HIF-1α), extracellular signal-regulated kinase 1/2 (ERK1/2) and Notch1 signaling pathways were respectively investigated by immunofluorescence assay or western blotting in vivo and oxygen–glucose-deprived (OGD) brain microvascular endothelial cells (BMECs); simultaneously, wound healing of BMECs and tube formation assay were administrated. Compared to MCAo group, SSS extraction could significantly improve neurological functional scores, survival rate and cerebral infarct volume, enhance vWF+ vascular density and perimeter, SDF-1α/CXCR4 axis, VEGF expression, as well as activate AKT/mTOR/HIF-1α and ERK1/2 and inhibit Notch1 pathways in penumbra. In vitro, containing SSS extraction serum increased BMEC migration, capillary formation and VEGF expression via up-regulations of AKT/mTOR and ERK1/2 pathways in OGD BMECs, but ERK inhibitor (U0126) reversed the result of VEGF expression in high dose of SSS group. Additionally, VEGFR2 and Notch1 expressions were suppressed by containing SSS extraction serum. All results were in dose dependent manner. Our study firstly demonstrates that SSS extraction is an angiogenic switch. Due to suppressed VEGFR2/Notch1 cascades and activated AKT/mTOR and ERK1/2 signals in BMECs, a feedback loop of angiogenic homeostasis is established. Furthermore, the comprehensive mediations of SDF-1α/CXCR4 axis, AKT/mTOR/HIF-α, ERK1/2 and Notch1 pathways in penumbra contribute to the improvements of neurological function, survival rate and infarct volume post-stroke. [Display omitted]
doi_str_mv 10.1016/j.phymed.2018.04.025
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2054965356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0944711318301259</els_id><sourcerecordid>2054965356</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-7e26291c01761f4b9694ffe9afc65064faf9f07cb2e6061841ea479a7e6655113</originalsourceid><addsrcrecordid>eNp9kcFu3CAQhlHVqNmmfYOq4thD7QUW8HKpFEVpEiVqpGQr9YZYdrDZ2mYDdpJ9hz50sDa59sQIvvln-H-EvlBSUkLlfFvumn0Hm5IRuiwJLwkT79CMSrosiBJ_3qMZUZwXFaWLY_QxpS0hlKuKfEDHTC2V4Es1Q__uG-jr0eN706epnAoMz0M0dvChxz7hfGH62ocaem9xevKDbfCjNzhCPbZmwhIODp9er-bd6vbuOz6_u6Zzlrs2-FfINMXJ171p8c4MzZPZZ003QMzitoFuEh1i-Auf0JEzbYLPr-cJ-v3zfHV2WdzcXlydnd4UdiHZUFTAJFPUElpJ6vhaScWdA2WclYJI7oxTjlR2zUCSbAenYHilTAVSCpHtOEHfDrq7GB5GSIPu8ibQtqaHMCbNiOBKioWQGeUH1MaQUgSnd9F3Ju41JXrKQW_1IQc95aAJ1zmH3Pb1dcK4nt7emt6Mz8CPAwD5n48eok7WQ29h4yPYQW-C__-EFzrHm5k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2054965356</pqid></control><display><type>article</type><title>Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Liu, Bowen ; Luo, Cheng ; Zheng, Zhaoguang ; Xia, Zhenyan ; Zhang, Qian ; Ke, Chienchih ; Liu, Renshyan ; Zhao, Yonghua</creator><creatorcontrib>Liu, Bowen ; Luo, Cheng ; Zheng, Zhaoguang ; Xia, Zhenyan ; Zhang, Qian ; Ke, Chienchih ; Liu, Renshyan ; Zhao, Yonghua</creatorcontrib><description>As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years. We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated. In present study, rats were subjected to permanent middle cerebral artery occlusion model (MCAo) and were treated with low, middle and high doses of SSS extraction. We assessed neurological function and survival rate, and measured infarct volume by 2,3,5-triphenyltetrazolium chloride staining on day 7 after ischemia. von Willebrand factor (vWF), stromal cell-derived factor-1 alpha (SDF-1α) /chemokine (C-X-C motif) receptor 4 (CXCR4) axis, vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) as well as protein kinase B (AKT)/mammalian target of rapamycin (mTOR) /hypoxia-inducible factor-1 alpha (HIF-1α), extracellular signal-regulated kinase 1/2 (ERK1/2) and Notch1 signaling pathways were respectively investigated by immunofluorescence assay or western blotting in vivo and oxygen–glucose-deprived (OGD) brain microvascular endothelial cells (BMECs); simultaneously, wound healing of BMECs and tube formation assay were administrated. Compared to MCAo group, SSS extraction could significantly improve neurological functional scores, survival rate and cerebral infarct volume, enhance vWF+ vascular density and perimeter, SDF-1α/CXCR4 axis, VEGF expression, as well as activate AKT/mTOR/HIF-1α and ERK1/2 and inhibit Notch1 pathways in penumbra. In vitro, containing SSS extraction serum increased BMEC migration, capillary formation and VEGF expression via up-regulations of AKT/mTOR and ERK1/2 pathways in OGD BMECs, but ERK inhibitor (U0126) reversed the result of VEGF expression in high dose of SSS group. Additionally, VEGFR2 and Notch1 expressions were suppressed by containing SSS extraction serum. All results were in dose dependent manner. Our study firstly demonstrates that SSS extraction is an angiogenic switch. Due to suppressed VEGFR2/Notch1 cascades and activated AKT/mTOR and ERK1/2 signals in BMECs, a feedback loop of angiogenic homeostasis is established. Furthermore, the comprehensive mediations of SDF-1α/CXCR4 axis, AKT/mTOR/HIF-α, ERK1/2 and Notch1 pathways in penumbra contribute to the improvements of neurological function, survival rate and infarct volume post-stroke. [Display omitted]</description><identifier>ISSN: 0944-7113</identifier><identifier>EISSN: 1618-095X</identifier><identifier>DOI: 10.1016/j.phymed.2018.04.025</identifier><identifier>PMID: 29895489</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Angiogenesis ; Animals ; Brain Ischemia - drug therapy ; Brain Ischemia - metabolism ; Cells, Cultured ; Chemokine CXCL12 - metabolism ; Disease Models, Animal ; Drugs, Chinese Herbal - chemistry ; Drugs, Chinese Herbal - pharmacology ; Endothelium, Vascular - cytology ; Homeostasis ; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism ; Infarction, Middle Cerebral Artery ; Ischemic stroke ; Mitogen-Activated Protein Kinase 3 - metabolism ; Mitogen-Activated Protein Kinases - metabolism ; Neovascularization, Physiologic - drug effects ; Proto-Oncogene Proteins c-akt - metabolism ; Rats ; Receptor, Notch1 - metabolism ; Receptors, CXCR4 - metabolism ; Shengui Sansheng San ; Stroke - drug therapy ; Stroke - metabolism ; TOR Serine-Threonine Kinases - metabolism ; Vascular Endothelial Growth Factor Receptor-2 - metabolism</subject><ispartof>Phytomedicine (Stuttgart), 2018-05, Vol.44, p.20-31</ispartof><rights>2018 Elsevier GmbH</rights><rights>Copyright © 2018 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-7e26291c01761f4b9694ffe9afc65064faf9f07cb2e6061841ea479a7e6655113</citedby><cites>FETCH-LOGICAL-c362t-7e26291c01761f4b9694ffe9afc65064faf9f07cb2e6061841ea479a7e6655113</cites><orcidid>0000-0002-0644-4687</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.phymed.2018.04.025$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29895489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Bowen</creatorcontrib><creatorcontrib>Luo, Cheng</creatorcontrib><creatorcontrib>Zheng, Zhaoguang</creatorcontrib><creatorcontrib>Xia, Zhenyan</creatorcontrib><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Ke, Chienchih</creatorcontrib><creatorcontrib>Liu, Renshyan</creatorcontrib><creatorcontrib>Zhao, Yonghua</creatorcontrib><title>Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke</title><title>Phytomedicine (Stuttgart)</title><addtitle>Phytomedicine</addtitle><description>As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years. We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated. In present study, rats were subjected to permanent middle cerebral artery occlusion model (MCAo) and were treated with low, middle and high doses of SSS extraction. We assessed neurological function and survival rate, and measured infarct volume by 2,3,5-triphenyltetrazolium chloride staining on day 7 after ischemia. von Willebrand factor (vWF), stromal cell-derived factor-1 alpha (SDF-1α) /chemokine (C-X-C motif) receptor 4 (CXCR4) axis, vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) as well as protein kinase B (AKT)/mammalian target of rapamycin (mTOR) /hypoxia-inducible factor-1 alpha (HIF-1α), extracellular signal-regulated kinase 1/2 (ERK1/2) and Notch1 signaling pathways were respectively investigated by immunofluorescence assay or western blotting in vivo and oxygen–glucose-deprived (OGD) brain microvascular endothelial cells (BMECs); simultaneously, wound healing of BMECs and tube formation assay were administrated. Compared to MCAo group, SSS extraction could significantly improve neurological functional scores, survival rate and cerebral infarct volume, enhance vWF+ vascular density and perimeter, SDF-1α/CXCR4 axis, VEGF expression, as well as activate AKT/mTOR/HIF-1α and ERK1/2 and inhibit Notch1 pathways in penumbra. In vitro, containing SSS extraction serum increased BMEC migration, capillary formation and VEGF expression via up-regulations of AKT/mTOR and ERK1/2 pathways in OGD BMECs, but ERK inhibitor (U0126) reversed the result of VEGF expression in high dose of SSS group. Additionally, VEGFR2 and Notch1 expressions were suppressed by containing SSS extraction serum. All results were in dose dependent manner. Our study firstly demonstrates that SSS extraction is an angiogenic switch. Due to suppressed VEGFR2/Notch1 cascades and activated AKT/mTOR and ERK1/2 signals in BMECs, a feedback loop of angiogenic homeostasis is established. Furthermore, the comprehensive mediations of SDF-1α/CXCR4 axis, AKT/mTOR/HIF-α, ERK1/2 and Notch1 pathways in penumbra contribute to the improvements of neurological function, survival rate and infarct volume post-stroke. [Display omitted]</description><subject>Angiogenesis</subject><subject>Animals</subject><subject>Brain Ischemia - drug therapy</subject><subject>Brain Ischemia - metabolism</subject><subject>Cells, Cultured</subject><subject>Chemokine CXCL12 - metabolism</subject><subject>Disease Models, Animal</subject><subject>Drugs, Chinese Herbal - chemistry</subject><subject>Drugs, Chinese Herbal - pharmacology</subject><subject>Endothelium, Vascular - cytology</subject><subject>Homeostasis</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</subject><subject>Infarction, Middle Cerebral Artery</subject><subject>Ischemic stroke</subject><subject>Mitogen-Activated Protein Kinase 3 - metabolism</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Rats</subject><subject>Receptor, Notch1 - metabolism</subject><subject>Receptors, CXCR4 - metabolism</subject><subject>Shengui Sansheng San</subject><subject>Stroke - drug therapy</subject><subject>Stroke - metabolism</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><subject>Vascular Endothelial Growth Factor Receptor-2 - metabolism</subject><issn>0944-7113</issn><issn>1618-095X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu3CAQhlHVqNmmfYOq4thD7QUW8HKpFEVpEiVqpGQr9YZYdrDZ2mYDdpJ9hz50sDa59sQIvvln-H-EvlBSUkLlfFvumn0Hm5IRuiwJLwkT79CMSrosiBJ_3qMZUZwXFaWLY_QxpS0hlKuKfEDHTC2V4Es1Q__uG-jr0eN706epnAoMz0M0dvChxz7hfGH62ocaem9xevKDbfCjNzhCPbZmwhIODp9er-bd6vbuOz6_u6Zzlrs2-FfINMXJ171p8c4MzZPZZ003QMzitoFuEh1i-Auf0JEzbYLPr-cJ-v3zfHV2WdzcXlydnd4UdiHZUFTAJFPUElpJ6vhaScWdA2WclYJI7oxTjlR2zUCSbAenYHilTAVSCpHtOEHfDrq7GB5GSIPu8ibQtqaHMCbNiOBKioWQGeUH1MaQUgSnd9F3Ju41JXrKQW_1IQc95aAJ1zmH3Pb1dcK4nt7emt6Mz8CPAwD5n48eok7WQ29h4yPYQW-C__-EFzrHm5k</recordid><startdate>20180515</startdate><enddate>20180515</enddate><creator>Liu, Bowen</creator><creator>Luo, Cheng</creator><creator>Zheng, Zhaoguang</creator><creator>Xia, Zhenyan</creator><creator>Zhang, Qian</creator><creator>Ke, Chienchih</creator><creator>Liu, Renshyan</creator><creator>Zhao, Yonghua</creator><general>Elsevier GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0644-4687</orcidid></search><sort><creationdate>20180515</creationdate><title>Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke</title><author>Liu, Bowen ; Luo, Cheng ; Zheng, Zhaoguang ; Xia, Zhenyan ; Zhang, Qian ; Ke, Chienchih ; Liu, Renshyan ; Zhao, Yonghua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-7e26291c01761f4b9694ffe9afc65064faf9f07cb2e6061841ea479a7e6655113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Angiogenesis</topic><topic>Animals</topic><topic>Brain Ischemia - drug therapy</topic><topic>Brain Ischemia - metabolism</topic><topic>Cells, Cultured</topic><topic>Chemokine CXCL12 - metabolism</topic><topic>Disease Models, Animal</topic><topic>Drugs, Chinese Herbal - chemistry</topic><topic>Drugs, Chinese Herbal - pharmacology</topic><topic>Endothelium, Vascular - cytology</topic><topic>Homeostasis</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</topic><topic>Infarction, Middle Cerebral Artery</topic><topic>Ischemic stroke</topic><topic>Mitogen-Activated Protein Kinase 3 - metabolism</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Rats</topic><topic>Receptor, Notch1 - metabolism</topic><topic>Receptors, CXCR4 - metabolism</topic><topic>Shengui Sansheng San</topic><topic>Stroke - drug therapy</topic><topic>Stroke - metabolism</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><topic>Vascular Endothelial Growth Factor Receptor-2 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Bowen</creatorcontrib><creatorcontrib>Luo, Cheng</creatorcontrib><creatorcontrib>Zheng, Zhaoguang</creatorcontrib><creatorcontrib>Xia, Zhenyan</creatorcontrib><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Ke, Chienchih</creatorcontrib><creatorcontrib>Liu, Renshyan</creatorcontrib><creatorcontrib>Zhao, Yonghua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Phytomedicine (Stuttgart)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Bowen</au><au>Luo, Cheng</au><au>Zheng, Zhaoguang</au><au>Xia, Zhenyan</au><au>Zhang, Qian</au><au>Ke, Chienchih</au><au>Liu, Renshyan</au><au>Zhao, Yonghua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke</atitle><jtitle>Phytomedicine (Stuttgart)</jtitle><addtitle>Phytomedicine</addtitle><date>2018-05-15</date><risdate>2018</risdate><volume>44</volume><spage>20</spage><epage>31</epage><pages>20-31</pages><issn>0944-7113</issn><eissn>1618-095X</eissn><abstract>As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years. We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated. In present study, rats were subjected to permanent middle cerebral artery occlusion model (MCAo) and were treated with low, middle and high doses of SSS extraction. We assessed neurological function and survival rate, and measured infarct volume by 2,3,5-triphenyltetrazolium chloride staining on day 7 after ischemia. von Willebrand factor (vWF), stromal cell-derived factor-1 alpha (SDF-1α) /chemokine (C-X-C motif) receptor 4 (CXCR4) axis, vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) as well as protein kinase B (AKT)/mammalian target of rapamycin (mTOR) /hypoxia-inducible factor-1 alpha (HIF-1α), extracellular signal-regulated kinase 1/2 (ERK1/2) and Notch1 signaling pathways were respectively investigated by immunofluorescence assay or western blotting in vivo and oxygen–glucose-deprived (OGD) brain microvascular endothelial cells (BMECs); simultaneously, wound healing of BMECs and tube formation assay were administrated. Compared to MCAo group, SSS extraction could significantly improve neurological functional scores, survival rate and cerebral infarct volume, enhance vWF+ vascular density and perimeter, SDF-1α/CXCR4 axis, VEGF expression, as well as activate AKT/mTOR/HIF-1α and ERK1/2 and inhibit Notch1 pathways in penumbra. In vitro, containing SSS extraction serum increased BMEC migration, capillary formation and VEGF expression via up-regulations of AKT/mTOR and ERK1/2 pathways in OGD BMECs, but ERK inhibitor (U0126) reversed the result of VEGF expression in high dose of SSS group. Additionally, VEGFR2 and Notch1 expressions were suppressed by containing SSS extraction serum. All results were in dose dependent manner. Our study firstly demonstrates that SSS extraction is an angiogenic switch. Due to suppressed VEGFR2/Notch1 cascades and activated AKT/mTOR and ERK1/2 signals in BMECs, a feedback loop of angiogenic homeostasis is established. Furthermore, the comprehensive mediations of SDF-1α/CXCR4 axis, AKT/mTOR/HIF-α, ERK1/2 and Notch1 pathways in penumbra contribute to the improvements of neurological function, survival rate and infarct volume post-stroke. [Display omitted]</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>29895489</pmid><doi>10.1016/j.phymed.2018.04.025</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0644-4687</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0944-7113
ispartof Phytomedicine (Stuttgart), 2018-05, Vol.44, p.20-31
issn 0944-7113
1618-095X
language eng
recordid cdi_proquest_miscellaneous_2054965356
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Angiogenesis
Animals
Brain Ischemia - drug therapy
Brain Ischemia - metabolism
Cells, Cultured
Chemokine CXCL12 - metabolism
Disease Models, Animal
Drugs, Chinese Herbal - chemistry
Drugs, Chinese Herbal - pharmacology
Endothelium, Vascular - cytology
Homeostasis
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Infarction, Middle Cerebral Artery
Ischemic stroke
Mitogen-Activated Protein Kinase 3 - metabolism
Mitogen-Activated Protein Kinases - metabolism
Neovascularization, Physiologic - drug effects
Proto-Oncogene Proteins c-akt - metabolism
Rats
Receptor, Notch1 - metabolism
Receptors, CXCR4 - metabolism
Shengui Sansheng San
Stroke - drug therapy
Stroke - metabolism
TOR Serine-Threonine Kinases - metabolism
Vascular Endothelial Growth Factor Receptor-2 - metabolism
title Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A24%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Shengui%20Sansheng%20San%20extraction%20is%20an%20angiogenic%20switch%20via%20regulations%20of%20AKT/mTOR,%20ERK1/2%20and%20Notch1%20signal%20pathways%20after%20ischemic%20stroke&rft.jtitle=Phytomedicine%20(Stuttgart)&rft.au=Liu,%20Bowen&rft.date=2018-05-15&rft.volume=44&rft.spage=20&rft.epage=31&rft.pages=20-31&rft.issn=0944-7113&rft.eissn=1618-095X&rft_id=info:doi/10.1016/j.phymed.2018.04.025&rft_dat=%3Cproquest_cross%3E2054965356%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2054965356&rft_id=info:pmid/29895489&rft_els_id=S0944711318301259&rfr_iscdi=true